Innoviva, Inc. (INVA)

NASDAQ: INVA · Real-Time Price · USD

23.85

+1.15 (5.07%)

At close: Feb 17, 2026, 4:00 PM EST

24.32

+0.47 (1.97%)

After-hours: Feb 17, 2026, 6:18 PM EST

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Biotechnology	358.71M	310.46M	331.34M	391.87M	336.79M
Biotechnology Growth	15.54%	-6.30%	-15.45%	16.35%	29.03%
Total	358.71M	310.46M	331.34M	391.87M	336.79M
Total Growth	15.54%	-6.30%	-15.45%	16.35%	29.03%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Great Britain	241.73M	238.85M	311.65M	391.87M	326.79M
Great Britain Growth	1.21%	-23.36%	-20.47%	19.91%	25.20%
Total	241.73M	238.85M	311.65M	391.87M	326.79M
Total Growth	1.21%	-23.36%	-20.47%	19.91%	25.20%

Source: S&P Global Market Intelligence.